The evolution of therapeutic modalities drives the adoption of single-use technologies.

Review of SUT Adoption in Biopharma Manufacturing

Despite its understandable hesitancy, the pharma industry is facing a need for more widespread adoption of cloud-based solutions.

Why Are Pharmaceutical Companies Reluctant to Adopt Cloud Technologies?

Given the criticality of fill/finish processes, it is clear that automation is the next technological step.

 Automating the Future of Fill/Finish

Topic

Articles

Bristol Myers Squibb collaborates with Anthropic to accelerate drug development, manufacturing quality systems, and regulatory documentation via AI integration.

BMS-Anthropic Signals AI Move in Drug Manufacturing Quality Systems

Portfolio Manager
Intensified Downstream Systems
Sartorius

Global Technical Product Specialist
Thermo Fisher Scientific

Stuart Tindal, Sartorius, and David Chau, Thermo Fisher, discuss automation, single-use technology limits, and predictive control shaping continuous bioprocessing's future.

Q&A: How Continuous Bioprocessing Is Evolving With Smarter Automation

Deborah Smook is co-founder and co-owner of TurboFil Packaging Machines.

Deborah Smook, co-founder and co-owner of TurboFil Packaging Machines, explains some of the challenges involved with prefilled syringe manufacturing. 

Overcoming Challenges in Prefilled Syringe Manufacturing

Adam Goldstein is senior director, R&D, Thermo Fisher Scientific.

Michelle Nolasco is staff engineer, systems design engineering, Thermo Fisher Scientific.

Building resilient, adaptable operations capable of evolving alongside the rapid transformation of the biologics industry is key for downstream processing.

Transforming Downstream Purification: Trends Shaping the Future of Biologics Manufacturing

Videos

This week, the industry saw rapid technological integration on the factory floor, a strategic shift toward globalized development networks, and leadership upheaval at the FDA. 

PharmTech Weekly Roundup-May 15, 2026

President 
     Concordia MCS, LLC
Scientific Advisor 
     SmartSkin Technologies

Senior Director
Education, Outreach, and Digital Experience
Open Biopharma Research and Training Institute

Mihaela Simianu and Austin Caudle join the show to discuss how digital container twins can improve pharma manufacturing, validation, and risk reduction.

Manufacturing Intelligence: Digital Twins Meet Pharma Containers

Valerie Bandy brings over 25 years of distinguished experience in healthcare leadership to her current role as Vice President Pharmacy Solutions at Tecsys. With a career marked by this steadfast leadership, she has consistently excelled in driving strategic initiatives and optimizing operational efficiency. In her present capacity, Valerie collaborates closely with sales, research and development, AI and marketing teams to refine pharmacy supply chain software solutions, leveraging her extensive expertise in healthcare operations, sales strategy, supply chain, consulting, and regulatory compliance. Prior to her tenure at Tecsys, Valerie held pivotal leadership roles at prominent healthcare institutions including Director of Pharmacy at Wellstar Atlanta Medical Center, System Director of Pharmacy operations at Trinity Health, and consulting firms including Deloitte Consulting where she was a Specialist Master, and PriceWaterhouse Coopers. Throughout her career, she has spearheaded initiatives that have significantly impacted pharmaceutical procurement, cost optimization, and operational excellence, managing multi-billion-dollar budgets with adept precision. Valerie's academic credentials include a Doctor of Pharmacy, an MBA, and a Bachelor of Science in Biology, underscoring her commitment to academic excellence and professional development. Driven by her passion for healthcare leadership, Valerie actively seeks opportunities that align with organizational missions and visions, embodying a steadfast dedication to advancing healthcare delivery and patient outcomes.


Valerie Bandy, Tecsys, explains how proactive vendor relationships, strategic drug allocation, and end-to-end visibility can prevent costly pharmaceutical supply disruptions.

Q&A: How Manufacturers Can Prevent Drug Shortage Crises

Bristol Myers Squibb’s Hengrui agreement underscores how China-based early development may influence portfolio and manufacturing decisions.

BMS-Hengrui Pact Highlights China’s Rising Role in Drug Development

Dennis Cantellops is an independent GMP and data integrity consultant and a former consumer safety officer for the US Food and Drug Administration.

This article evaluates a structured, risk-based framework for the development, execution, and life cycle governance of master production and control records and batch production and control records systems aligned with current good manufacturing practice requirements and internationally harmonized pharmaceutical quality system guidance.

Risk-Based Life Cycle Management of Master Production and Control Records to Strengthen Data Integrity and GMP Inspection Readiness Part 1: Regulatory Framework, Inspectional Findings, and Documentation System Evaluation 

James E. Akers is the president of Akers Kennedy & Associates, PO Box 22562, Kansas City, MO 64113, akainckc@aol.com.

Automation, isolators, and AI-driven analytics are reshaping aseptic filling while boosting sterility assurance, flexibility, and GMP compliance.